Literature DB >> 24688022

Differential ability of surface and endosomal TLRs to induce CD8 T cell responses in vivo.

Rajakumar Mandraju1, Sean Murray, James Forman, Chandrashekhar Pasare.   

Abstract

TLR activation on dendritic cells (DCs) induces DC maturation and secretion of proinflammatory cytokines, both of which are important for activation and differentiation of CD4 T cells. The importance of TLR activation on DCs for CD8 T cell responses is less clear. In this study, we tested the ability of different TLRs to regulate CD8 T cell responses to pathogens. We found that although all TLRs are able to induce CD8 T cell activation in vitro, there are profound differences in their ability to activate CD8 T cells in vivo. The nucleic acid recognizing endosomal TLRs, TLR3 and TLR9, had a potent ability to induce CD8 T cell activation. However, the surface TLRs, TLR2 and TLR4, that recognize bacterial ligands were not only incapable of inducing CD8 T cell priming, but they had a dominant effect of inhibiting CD8 T cell expansion induced by activation of endosomal TLRs. We found that TLR2 and TLR4, acting in a MyD88-dependent manner, influenced CD8 T cell priming by altering the composition of DCs in the draining lymph nodes. Our results have important implications for combined bacterial and viral infections and suggest that bacterial infections could constrain the ability of the host to mount effective antiviral CD8 T cell immunity.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24688022      PMCID: PMC4002505          DOI: 10.4049/jimmunol.1302244

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  60 in total

Review 1.  Cross-presentation, dendritic cells, tolerance and immunity.

Authors:  W R Heath; F R Carbone
Journal:  Annu Rev Immunol       Date:  2001       Impact factor: 28.527

Review 2.  Toll-like receptors: critical proteins linking innate and acquired immunity.

Authors:  S Akira; K Takeda; T Kaisho
Journal:  Nat Immunol       Date:  2001-08       Impact factor: 25.606

Review 3.  Antigen presentation and T cell stimulation by dendritic cells.

Authors:  Pierre Guermonprez; Jenny Valladeau; Laurence Zitvogel; Clotilde Théry; Sebastian Amigorena
Journal:  Annu Rev Immunol       Date:  2001-10-04       Impact factor: 28.527

4.  A subset of Toll-like receptor ligands induces cross-presentation by bone marrow-derived dendritic cells.

Authors:  Sandip K Datta; Vanessa Redecke; Kiley R Prilliman; Kenji Takabayashi; Maripat Corr; Thomas Tallant; Joseph DiDonato; Roman Dziarski; Shizuo Akira; Stephen P Schoenberger; Eyal Raz
Journal:  J Immunol       Date:  2003-04-15       Impact factor: 5.422

5.  CpG-DNA aided cross-presentation of soluble antigens by dendritic cells.

Authors:  Tobias Maurer; Antje Heit; Hubertus Hochrein; Franziska Ampenberger; Meredith O'Keeffe; Stefan Bauer; Grayson B Lipford; Ramunas M Vabulas; Hermann Wagner
Journal:  Eur J Immunol       Date:  2002-08       Impact factor: 5.532

6.  Spatial and mechanistic separation of cross-presentation and endogenous antigen presentation.

Authors:  Sven Burgdorf; Christian Schölz; Andreas Kautz; Robert Tampé; Christian Kurts
Journal:  Nat Immunol       Date:  2008-03-30       Impact factor: 25.606

7.  Cutting edge: control of CD8+ T cell activation by CD4+CD25+ immunoregulatory cells.

Authors:  C A Piccirillo; E M Shevach
Journal:  J Immunol       Date:  2001-08-01       Impact factor: 5.422

Review 8.  Role of adapters in Toll-like receptor signalling.

Authors:  S Akira; M Yamamoto; K Takeda
Journal:  Biochem Soc Trans       Date:  2003-06       Impact factor: 5.407

Review 9.  Toll-like receptors.

Authors:  Kiyoshi Takeda; Tsuneyasu Kaisho; Shizuo Akira
Journal:  Annu Rev Immunol       Date:  2001-12-19       Impact factor: 28.527

10.  Synergism of cytotoxic T lymphocyte-associated antigen 4 blockade and depletion of CD25(+) regulatory T cells in antitumor therapy reveals alternative pathways for suppression of autoreactive cytotoxic T lymphocyte responses.

Authors:  R P Sutmuller; L M van Duivenvoorde; A van Elsas; T N Schumacher; M E Wildenberg; J P Allison; R E Toes; R Offringa; C J Melief
Journal:  J Exp Med       Date:  2001-09-17       Impact factor: 14.307

View more
  19 in total

1.  Promising Role of Toll-Like Receptor 8 Agonist in Concert with Prostratin for Activation of Silent HIV.

Authors:  M A Rochat; E Schlaepfer; R F Speck
Journal:  J Virol       Date:  2017-01-31       Impact factor: 5.103

Review 2.  Modulating the immune system through nanotechnology.

Authors:  Tamara G Dacoba; Ana Olivera; Dolores Torres; José Crecente-Campo; María José Alonso
Journal:  Semin Immunol       Date:  2017-10-09       Impact factor: 11.130

Review 3.  Innate Control of Adaptive Immunity: Beyond the Three-Signal Paradigm.

Authors:  Aakanksha Jain; Chandrashekhar Pasare
Journal:  J Immunol       Date:  2017-05-15       Impact factor: 5.422

4.  Multiple low-dose challenges in a rhesus macaque AIDS vaccine trial result in an evolving host response that affects protective outcome.

Authors:  Christian Selinger; Natasa Strbo; Louis Gonzalez; Lauri Aicher; Jeffrey M Weiss; G Lynn Law; Robert E Palermo; Monica Vaccari; Genoveffa Franchini; Eckhard R Podack; Michael G Katze
Journal:  Clin Vaccine Immunol       Date:  2014-10-01

5.  Chitosan hydrogel vaccine generates protective CD8 T cell memory against mouse melanoma.

Authors:  Andrew J Highton; Thunjiradasiree Kojarunchitt; Adam Girardin; Sarah Hook; Roslyn A Kemp
Journal:  Immunol Cell Biol       Date:  2015-02-24       Impact factor: 5.126

6.  Liver-resident CD103+ dendritic cells prime antiviral CD8+ T cells in situ.

Authors:  Peter D Krueger; Taeg S Kim; Sun-Sang J Sung; Thomas J Braciale; Young S Hahn
Journal:  J Immunol       Date:  2015-02-23       Impact factor: 5.422

Review 7.  Peptide vaccines in cancer-old concept revisited.

Authors:  Takumi Kumai; Hiroya Kobayashi; Yasuaki Harabuchi; Esteban Celis
Journal:  Curr Opin Immunol       Date:  2016-12-09       Impact factor: 7.486

Review 8.  Crosstalk between innate and adaptive immunity in hepatitis B virus infection.

Authors:  Li Wang; Kai Wang; Zhi-Qiang Zou
Journal:  World J Hepatol       Date:  2015-12-28

Review 9.  Modifying the tumor microenvironment using nanoparticle therapeutics.

Authors:  Aniruddha Roy; Shyh-Dar Li
Journal:  Wiley Interdiscip Rev Nanomed Nanobiotechnol       Date:  2016-04-01

Review 10.  Synthetic Nanoparticles for Vaccines and Immunotherapy.

Authors:  Darrell J Irvine; Melissa C Hanson; Kavya Rakhra; Talar Tokatlian
Journal:  Chem Rev       Date:  2015-07-08       Impact factor: 60.622

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.